Skip to content

Clinical trials

Completed Phase 1 Neurodegenerative Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Phase: Phase 1 Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20112
20121
20142
20151
20172
20192
20202
20212
20222
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MODAG GmbH3
Affiris AG2
Siena Biotech S.p.A.2
Abrexa Pharmaceuticals, Inc.1
Cerevel Therapeutics, LLC1
Columbia University1
Hanyang University Seoul Hospital1
Herantis Pharma Plc.1
Institute for Neurodegenerative Disorders1
LeonaBio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases21
Alzheimer Disease7
Central Nervous System Diseases7
Parkinson Disease7
Brain Diseases5
Nervous System Diseases5
Dementia4
Movement Disorders4
Multiple System Atrophy4
Amyotrophic Lateral Sclerosis3

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.